Zhongshan Ophthalmic Center, Sun Yat-sen University

This early-phase study tests a new gene therapy drug, ZVS106e, for people with a rare inherited eye disease called Stargardt disease, which causes progressive vision loss. The treatment is given as a single injection under the retina in one eye. The main goal is to check if the t…